Value-based healthcare is influencing the adoption of robotic surgery by emphasizing cost savings, efficiency, and improved patient outcomes. (Credit: Damian/AdobeStock)

In recent years, significant advancements in robotics, artificial intelligence (AI), and medical imaging have driven the growth of robotic surgery, enabling complex procedures with greater precision and reduced complications. Robotic surgical systems now incorporate high-definition 3D imaging and microscale instruments, enhancing surgeons’ ability to navigate delicate anatomical structures with minimal tissue damage. The development of remote telesurgery has also improved access to specialized care, overcoming geographical barriers.

The rising demand for minimally invasive surgery (MIS), due to its benefits of smaller incisions, reduced trauma, and quicker recovery times, has further fueled the adoption of robotic systems. These systems align with the patient demand for less invasive procedures and shorter hospital stays, particularly benefiting the growing elderly population. Value-based healthcare is influencing the adoption of robotic surgery by emphasizing cost savings, efficiency, and improved patient outcomes.

In this Q&A, Graysen Vigneux, medical analyst at GlobalData, explores how AI and machine learning are playing crucial roles in enhancing the precision and safety of these devices, enabling remote surgeries, and providing real-time assistance during operations. He discusses the collaboration between healthcare, tech, and investment sectors, and how they are driving innovation, with significant investments supporting the development and commercialization of advanced robotic systems.

MDB: What specific technological advancements in robotic surgery are driving the projected growth in 2024 and beyond?
Graysen Vigneux, Medical Analyst at GlobalData

Graysen Vigneux: Significant advancements in robotics, artificial intelligence (AI), and medical imaging have made robotic surgery a reality, allowing surgeons to seamlessly blend human skill with robotic precision. These advancements enable the performance of complex procedures with greater finesse and accuracy. Robotic surgical systems incorporate advanced visualization technologies, such as high-definition 3D imaging, providing surgeons with a clearer view of the surgical site. This enhanced visualization improves their ability to see complex anatomical structures and perform intricate tasks. Furthermore, the use of microscale instruments allows surgeons to navigate through delicate anatomical structures with unmatched precision, minimizing damage to surrounding tissues and reducing blood loss. The development of remote telesurgery capabilities has also revolutionized surgical practices, enabling experienced surgeons to conduct operations from a distance and guide their colleagues in regions with limited advanced medical facilities. This technology holds the potential to improve access to specialized medical treatment, break down geographical barriers, and ensure that patients everywhere can receive top-notch care.

MDB: How do you anticipate the surge in demand for minimally invasive procedures will impact the adoption and utilization of robotic surgical systems?

GV: The increasing demand for minimally invasive surgery (MIS), driven by the preference for smaller incisions, reduced trauma, and quicker recovery times, has fueled the growth of the global surgical robotics market. Robotic surgical systems offer greater efficiency, precision, and reduced complications, aligning with the patient demand for less pain and shorter hospital stays. The rise in gynecological, neurological, and urological diseases further drives market growth, as robotic surgery provides minimally invasive solutions with better precision and reduced discomfort. Additionally, the growing elderly population, which is at higher risk for conditions requiring surgical interventions, contributes to the increased demand for robotic systems. Furthermore, robotic surgery offers cost savings and efficiency by reducing hospital stays and the risk of hospital-acquired infections, benefiting both patients and healthcare providers.

MDB: Can you elaborate on how the focus on value-based healthcare is influencing the adoption of robotic surgery systems and accessories?

GV: Robotic surgery systems offer greater efficiency and cost savings compared to traditional surgical methods by allowing surgeons to operate with greater precision, reducing complications, and resulting in faster recovery periods. This not only leads to cost savings for patients and healthcare providers but also reduces the risk of hospital-acquired infections. Additionally, because robotic surgery is less invasive, patients typically require shorter hospital stays, further contributing to cost savings. The demand for more cost-effective solutions in healthcare, especially during economic downturns, has spurred increased interest in surgical robotics systems. These systems, with their enhanced efficiency and cost-effectiveness, are becoming an attractive option for healthcare providers. The market for surgical robotics is also driven by the availability of improved healthcare infrastructure, an increase in unmet healthcare needs, a rise in the prevalence of chronic diseases, and a surge in demand for advanced surgical robotics products. These systems incorporate advanced visualization technologies, such as high-definition 3D imaging and augmented reality, which enhance surgeons’ ability to visualize complex anatomical structures and perform intricate tasks. Furthermore, emerging markets like Brazil, India, and China present lucrative opportunities for the expansion of surgical robotics due to their increasing healthcare expenditure, leading to broader access to these advanced systems. Overall, the focus on value-based healthcare is driving the adoption of robotic surgery systems and accessories by emphasizing efficiency, cost savings, and improved patient outcomes.

MDB: What role do you see artificial intelligence and machine learning algorithms playing in the future development of robotic surgery devices?

GV: AI-powered robotic surgery devices enable remote surgery, allowing surgeons to perform procedures from a different location than the patient, enhancing access to specialized surgical expertise in remote or underserved areas. Additionally, AI can automate certain aspects of surgery, reducing the workload on surgeons and improving the quality and safety of procedures. AI algorithms also provide real-time assistance during surgeries, particularly those involving video monitors like robotic or laparoscopic surgeries, by predicting the next steps of an operation and visually informing the surgeon to improve outcomes. The integration of AI and machine learning algorithms in robotic surgery devices enhances precision and accuracy, leading to better patient outcomes and enabling minimally invasive procedures that reduce recovery time and associated costs. Moreover, nanosurgery, where microrobots operate on individual cells, represents a potential application of medical robotics. While AI’s primary focus in medical devices is currently on diagnostics, its incorporation into surgical procedures is growing, helping healthcare professionals make quicker and more reliable diagnostic decisions and revolutionizing patient treatment.

MDB: How are stakeholders in the healthcare, tech, and investment sectors collaborating to drive innovation in the field of robotic surgery?

GV: Major manufacturers in the medical device industry are intensifying their research and development efforts within robotic surgical systems, highlighting the collaboration between healthcare and tech sectors to create advanced robotic technologies for surgery. Companies in the robotics industry are also forming co-development agreements to improve the surgical planning experience and workflow efficiency for surgeons. For instance, Think Surgical has partnered with Definition Health to develop a seamless, web-based, connected care solution for joint replacement surgery. Moreover, the investment sector plays a crucial role in driving innovation in robotic surgery. Significant investment is needed to develop and commercialize these systems, with for-profit entities leading the initial adoption, particularly in outpatient ambulatory surgery centers. Early leaders in the field are spurring widespread adoption in hospitals and public healthcare systems, demonstrating the synergy between the investment sector and healthcare providers to fund and support the implementation of robotic surgery.

MDB: With the expanding elderly demographic, how are robotic surgery systems catering to the unique needs and challenges of this patient population?

GV : Robotic surgery systems assist surgeons in handling the complexities of surgical procedures, leading to safer and more effective outcomes for elderly patients. These advanced technologies are being adapted for a broader spectrum of surgeries across various medical fields, including cardiac, neurology, urology, gynecology, and more, enabling less invasive procedures that benefit elderly patients by reducing recovery time and associated costs. Future developments in robotic surgery systems aim to further enhance the quality of life for elderly patients by minimizing invasiveness and thereby shortening recovery periods and lowering expenses. Additionally, robotic surgery systems can reduce the cost of nursing care by performing simple tasks, such as helping patients get into and out of bed, which decreases nursing costs and allows nurses to focus on other important duties. The versatility of these systems also attracts hospitals and clinics seeking to offer comprehensive robotic surgical services, effectively meeting the increasing demand for surgical interventions among the aging population.

MDB: What are the potential barriers or challenges that could hinder the anticipated growth of the robotic surgery market in the coming years?
Market value of robotic surgical systems. (Credit: GlobalData)

GV: Potential barriers or challenges that could hinder the anticipated growth of the robotic surgery market in the coming years include the high cost of robotic surgical systems, which encompasses acquisition, implementation, and maintenance. This financial burden can limit the ability of hospitals and healthcare facilities to invest in this technology, particularly in regions with regulated budgets and limited government spending on expensive surgical robotics systems. Additionally, the intricate nature of surgical robotics necessitates specialized training for surgeons, leading to a potential shortage of skilled professionals and thereby hindering the rapid expansion of the surgical robotics market, especially in developing regions. Moreover, regulatory complexities and patient safety concerns, along with the need for rigorous clinical validation of robotic procedures, can slow down the adoption process of robotic surgery. The evolving regulations and increasing demand for clinical validation and usability testing further complicate the widespread adoption of surgical robotics.

MDB: How do you foresee regulatory bodies adapting to the rapid evolution of robotic surgery technologies to ensure patient safety and efficacy?

GV: Regulatory bodies are likely to adapt to the rapid evolution of robotic surgery technologies by implementing stricter regulations and certification processes to ensure patient safety and efficacy. Current regulatory frameworks, such as the FDA’s class system in the United States and the CE Mark certification in Europe, categorize medical devices based on their invasiveness and risk level, with more invasive devices requiring more regulation. Robotic surgical systems must undergo rigorous certification processes like the FDA’s 510(k) clearance or CE Mark certification before they can be marketed and sold. The FDA’s approval time for these systems can range from four to six months, excluding the initial paperwork and document submission. Additionally, there is a growing demand for clinical validation and usability testing in the regulatory process, and regulations are likely to evolve to incorporate more autonomy through AI and machine learning.

MDB: Can you discuss any emerging trends or niche areas within robotic surgery that present significant growth opportunities in the near future?

GV: Growth opportunities in the near future include an upsurge in R&D efforts by major manufacturers such as Johnson & Johnson and Medtronic, signaling a heightened emphasis on innovation and the advancement of new technologies within the field. Additionally, the landscape of the market is swiftly evolving with the emergence of new players alongside the dominant presence of Intuitive Surgical, fostering increased competition that is poised to propel market growth and foster further technological advancements. Furthermore, there is a notable shift towards addressing the healthcare needs of the elderly population, with a focus on enhancing their quality of life through less invasive procedures, shorter recovery times, and reduced costs. Robotic surgery stands as a promising avenue for improving healthcare outcomes and catering to the unique requirements of aging individuals.

For more information, visit here .